Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202, United States
Location status: Recruiting
NCT Number: NCT07761910
Prospective clinical study designed to evaluate damage to the heart after receiving standard of care chemotherapy and radiation therapy for locally advanced Non-Small Cell Lung Cancer (NSCLC).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 2
Indianapolis, Indiana, 46202, United States
Location status: Recruiting
As the survival for NSCLC has gradually improved, there is increasing concern about long term radiation-induced cardiac toxicities and support in minimizing the dose to the left anterior descending artery. Myocardial perfusion (the delivery of blood to the heart muscle) evaluated by PET CT scans could be a useful tool to assess early cardiac damage by radiation, so this study will prospectively and quantitatively assess myocardial blood flow and myocardial flow reserve with 18F-Flurpiridaz PET CT prior to and after radiation therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exclusion for Coronary computed tomography angiography (CCTA)
Exclusion for 18F-Flurpiridaz PET/CT Test
Note: Resting 12-lead EKG will be ordered at the time of enrollment to be performed prior to PET/CT stress test.
A two-phase, rest and regadenoson stress evaluated by 18F-Flurpiridaz PET/CT before and 3 months after SOC radiation treatment.
Coronary computed tomographic angiography (CCTA) scan is a highly accurate noninvasive technique for detection of coronary artery plaque.
A two-phase, rest and regadenoson stress evaluated by 18F-Flurpiridaz PET/CT before and 3 months after SOC radiation treatment
Time frame: Pre-radiotherapy and 3 months post-radiotherapy
Assessed using a two-phase, rest and regadenoson stress evaluated by 18F-Flurpiridaz PET/CT
Time frame: Pre-radiotherapy and 3 months post-radiotherapy
Assessed using a two-phase, rest and regadenoson stress evaluated by 18F-Flurpiridaz PET/CT
Time frame: Pre-radiotherapy and 3 months post-radiotherapy
Assessed using a two-phase, rest and regadenoson stress evaluated by 18F-Flurpiridaz PET/CT
Time frame: Pre-radiotherapy and 3 months post-radiotherapy
Assessed using a two-phase, rest and regadenoson stress evaluated by 18F-Flurpiridaz PET/CT
Time frame: Pre-radiotherapy and 3 months post-radiotherapy
Assessed using a two-phase, rest and regadenoson stress evaluated by 18F-Flurpiridaz PET/CT
Contact information is provided by the study sponsor or research team.
Indiana University
Other
Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06694454
Bronchial Neoplasms, Carcinoma, Bronchogenic
Bethesda, Maryland, United States
View Trial DetailsNCT07718243
Bronchial Neoplasms, Carcinoma, Bronchogenic
Manchester, United Kingdom
View Trial DetailsNCT06242470
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT07174388
Bronchial Neoplasms, Carcinoma, Bronchogenic
Monterey, California, United States
View Trial Details